Histological analyses of tumor samples from patients undergoing neoadjuvant chemotherapy have frequently documented the accumulation of cells expressing high levels of p16INK4a and senescence-associated β-galactosidase (SA-β-gal). This evidence concerns the gene CDKN2A and neoplasm.